InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Wallace Max N., Director. Director active across 1 company, notably Humacyte, Inc.. In total, 4 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 21 November 2023. The latest transaction was disclosed on 20 May 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
4,015 shares@ US$6.2176.3% of flowCommon StockSEC:0001818382-24-000067:0
Ideal exit: 14 Feb 2025 (T+270)
6,564 shares@ US$1.1923.7% of flowCommon StockSEC:0001818382-23-000165:0
49,986 sharesCommon StockSEC:0001104659-21-110531:0
49,986 sharesCommon StockSEC:0001104659-21-110531
4 of 4 declarations
About Wallace Max N.
Max N. Wallace is a Board Member at Humacyte, Inc. As a board member, he participates in the governance and oversight of the company's activities. His experience in the biotechnology sector is an asset to the board.
